Physician Biologics Solutions GPO Expands Exosome Therapy Line

Written by

Regenerative Biologics GPO Offers Cord Blood Exosome Therapy and Perinatal Products to Physicians Nationwide

Orlando, United States – April 17, 2026 / Platinum Biologics /

Platinum Biologics, a physician-centric group purchasing organization (GPO) specializing in regenerative biologics, has announced the expansion of its exosome therapy product line, adding new cord blood-derived options to its existing portfolio of perinatal products available to physicians across the United States. The expansion positions the company to serve a broader range of clinical specialties seeking access to biologic therapies processed in FDA-registered, cGMP-compliant facilities.

Expanded Portfolio Addresses Physician Access to Perinatal-Derived Biologics

The newly expanded line includes cord blood-based exosome therapy products alongside perinatal-derived scaffolds, all manufactured under current Good Manufacturing Practice (cGMP) standards. Each lot undergoes third-party testing before distribution, providing physicians with documented quality assurance at the product level. Platinum Biologics operates as a nationwide GPO, allowing clinicians to access these products through a structured procurement model that removes many of the logistical barriers associated with sourcing specialty biologics independently.

The company pairs product access with peer-to-peer medical education led by licensed physicians. This MD-guided support structure is designed to help clinicians make informed decisions about integrating biologic therapies into patient care protocols, particularly for practices that may be introducing these product categories for the first time.

Logistics and Quality Standards Central to the GPO Model

Platinum Biologics has built its distribution infrastructure around overnight delivery to ensure product integrity from origin to clinical setting. The company’s physician biologics solutions model consolidates procurement, education, and logistics into a single framework, reducing administrative complexity for practices operating in specialties such as orthopedics, pain management, wound care, and sports medicine.

All products distributed through the GPO are sourced from FDA-registered facilities and tested by independent third-party laboratories, with results made available to purchasing physicians. This transparency layer is a deliberate component of the company’s quality assurance process, intended to support physician confidence in the products they administer.

“With this expansion, Platinum Biologics now offers physicians access to more than 15 distinct perinatal and cord blood-derived products through a single GPO relationship, all backed by third-party lot testing and overnight delivery in all 50 states,” said Dr. Michael Harlan, Chief Medical Officer of Platinum Biologics. “Physicians should not have to choose between product quality and affordability, and this expanded line reflects our commitment to making that trade-off unnecessary.”

Nationwide Reach Through a Physician-First GPO Structure

The GPO model employed by Platinum Biologics is structured specifically for individual physician practices and group practices rather than hospital systems. By aggregating purchasing across its network, the organization is able to offer competitive pricing on regenerative biologics without requiring high-volume commitments from participating clinicians.

Physicians who join the GPO gain access to the full product catalog, including the newly expanded exosome therapy line, at negotiated pricing with no membership fees disclosed as a barrier to entry. The company has positioned this structure as a practical pathway for independent practitioners to add biologic therapy options to their clinical offerings without significant upfront investment in sourcing infrastructure.

Platinum Biologics also provides onboarding support and continuing education resources for new GPO members, including documentation on regulatory compliance and product application, all delivered through its MD-led advisory team. This educational component is particularly relevant as more physicians across multiple specialties evaluate regenerative biologics as part of expanded patient care offerings.

About Platinum Biologics

Platinum Biologics is a physician-centric GPO specializing in regenerative biologics, offering a curated portfolio of perinatal-derived scaffolds and cord blood-based exosome therapy products to clinicians nationwide. The company sources products exclusively from FDA-registered, cGMP-compliant facilities, supports physicians with MD-led guidance and third-party lot testing, and delivers through a nationwide overnight logistics network.

Learn more at Platinum Biologics